D3 Bio
Last updated: October 09, 2024

George Chen, CEO
China | Funding: $262M (+)
Website: https://www.d3bio.com/
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.
Website: https://www.d3bio.com/
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.